Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease.

[1]  J. Ordovás,et al.  Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[2]  H. Brewer,et al.  Plasma Phospholipid Transfer Protein , 1997, The Journal of Biological Chemistry.

[3]  M. Taskinen,et al.  Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. , 1996, Atherosclerosis.

[4]  A. Tall,et al.  Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. , 1996, The Journal of clinical investigation.

[5]  J. Albers,et al.  Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. , 1996, Biochimica et biophysica acta.

[6]  A. von Eckardstein,et al.  Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. , 1996, Biochimica et biophysica acta.

[7]  B. Paigen,et al.  Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio , 1996, International journal of clinical & laboratory research.

[8]  M. Jauhiainen,et al.  The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. , 1996, The Biochemical journal.

[9]  W. Boron,et al.  Fluid absorption in isolated perfused colonic crypts. , 1995, The Journal of clinical investigation.

[10]  J. Albers,et al.  Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. , 1995, Biochimica et biophysica acta.

[11]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[12]  J. Fruchart,et al.  Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk. , 1994, Atherosclerosis.

[13]  T. Nishida,et al.  High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. , 1993, The Journal of biological chemistry.

[14]  E. Rubin,et al.  Protein composition determines the anti-atherogenic properties of HDL in transgenic mice , 1993, Nature.

[15]  M. Austin,et al.  Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia. , 1993, Atherosclerosis.

[16]  J. Qiao,et al.  Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. , 1993, Science.

[17]  M. Jauhiainen,et al.  Human plasma phospholipid transfer protein causes high density lipoprotein conversion. , 1993, The Journal of biological chemistry.

[18]  D. Rader,et al.  In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. , 1991, Journal of lipid research.

[19]  R. Krauss,et al.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.

[20]  B. G. Brown,et al.  Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. , 1991, Journal of lipid research.

[21]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[22]  M. Cheung,et al.  In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins. , 1989, Journal of lipid research.

[23]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[24]  J. Albers,et al.  Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. , 1988, Journal of lipid research.

[25]  A. Zinsmeister,et al.  Apolipoproteins and coronary artery disease. , 1986, Mayo Clinic proceedings.

[26]  Warnick Gr.  Enzymatic methods for quantification of lipoprotein lipids. , 1986 .

[27]  P. Bachorik,et al.  Precipitation methods for quantification of lipoproteins. , 1986, Methods in enzymology.

[28]  A. Tall,et al.  Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. , 1985, Journal of lipid research.

[29]  J. Albers,et al.  Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. , 1984, The Journal of biological chemistry.

[30]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[31]  J. Albers,et al.  Precipitation of 125 I-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins. , 1971, Biochemistry.